BBR Partners LLC Makes New $5.39 Million Investment in Humana Inc. (NYSE:HUM)

BBR Partners LLC purchased a new position in Humana Inc. (NYSE:HUM - Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm purchased 21,255 shares of the insurance provider's stock, valued at approximately $5,393,000. Humana comprises about 0.4% of BBR Partners LLC's portfolio, making the stock its 25th largest position.

A number of other large investors have also added to or reduced their stakes in HUM. FMR LLC grew its holdings in Humana by 23.4% in the 3rd quarter. FMR LLC now owns 3,388,859 shares of the insurance provider's stock worth $1,073,387,000 after acquiring an additional 643,291 shares during the last quarter. Thrivent Financial for Lutherans boosted its stake in shares of Humana by 55.6% during the 3rd quarter. Thrivent Financial for Lutherans now owns 600,317 shares of the insurance provider's stock valued at $190,145,000 after purchasing an additional 214,535 shares in the last quarter. Retirement Systems of Alabama boosted its stake in shares of Humana by 735.9% during the 4th quarter. Retirement Systems of Alabama now owns 219,002 shares of the insurance provider's stock valued at $55,563,000 after purchasing an additional 192,801 shares in the last quarter. Pzena Investment Management LLC boosted its stake in Humana by 8.1% during the third quarter. Pzena Investment Management LLC now owns 2,506,250 shares of the insurance provider's stock worth $793,830,000 after acquiring an additional 187,903 shares in the last quarter. Finally, Worldquant Millennium Advisors LLC bought a new stake in Humana during the third quarter worth about $50,102,000. Institutional investors own 92.38% of the company's stock.

Remove Ads

Humana Stock Performance

Shares of HUM traded down $5.90 during mid-day trading on Friday, hitting $259.86. 1,552,919 shares of the company traded hands, compared to its average volume of 1,673,380. The company has a debt-to-equity ratio of 0.68, a quick ratio of 1.76 and a current ratio of 1.76. The stock has a 50-day moving average price of $271.80 and a two-hundred day moving average price of $283.63. Humana Inc. has a 1 year low of $213.31 and a 1 year high of $406.46. The stock has a market cap of $31.35 billion, a price-to-earnings ratio of 26.12, a P/E/G ratio of 2.05 and a beta of 0.57.

Humana (NYSE:HUM - Get Free Report) last released its quarterly earnings data on Tuesday, February 11th. The insurance provider reported ($2.16) earnings per share for the quarter, beating the consensus estimate of ($2.26) by $0.10. Humana had a net margin of 1.02% and a return on equity of 11.70%. Equities analysts anticipate that Humana Inc. will post 16.47 earnings per share for the current year.

Humana Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, April 25th. Investors of record on Friday, March 28th will be given a dividend of $0.885 per share. The ex-dividend date is Friday, March 28th. This represents a $3.54 annualized dividend and a yield of 1.36%. Humana's dividend payout ratio (DPR) is 35.58%.

Wall Street Analyst Weigh In

Several research firms recently commented on HUM. StockNews.com lowered shares of Humana from a "buy" rating to a "hold" rating in a research note on Wednesday. Piper Sandler boosted their price objective on shares of Humana from $270.00 to $288.00 and gave the stock a "neutral" rating in a research note on Wednesday, January 15th. Royal Bank of Canada reissued an "outperform" rating and set a $283.00 price objective on shares of Humana in a research note on Wednesday, February 12th. Cantor Fitzgerald reissued a "neutral" rating and set a $290.00 price objective on shares of Humana in a research note on Wednesday, February 12th. Finally, Truist Financial boosted their price objective on shares of Humana from $260.00 to $290.00 and gave the stock a "hold" rating in a research note on Monday, January 6th. Twenty research analysts have rated the stock with a hold rating and five have given a buy rating to the company's stock. Based on data from MarketBeat.com, Humana currently has an average rating of "Hold" and a consensus target price of $285.68.

Insider Activity at Humana

In related news, insider Timothy S. Huval sold 3,703 shares of the business's stock in a transaction that occurred on Tuesday, December 31st. The shares were sold at an average price of $256.26, for a total transaction of $948,930.78. Following the completion of the sale, the insider now directly owns 8,181 shares in the company, valued at approximately $2,096,463.06. The trade was a 31.16 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. 0.32% of the stock is currently owned by company insiders.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.